The goal of research with receptor ligands and PET is the characterization of an in vivo system that mea sures rates of association and dissociation of a Iigand receptor complex and the density of available binding sites. It has been suggested that multiple injection studies of radioactive ligand are more likely to identify model parameters than are single injection studies. Typically, at least one of the late injections is at a low specific activity (SA), so that part of the positron emission tomography (PET) curve reflects ligand dissociation . Low SA injec tions and the attendant reductions in receptor availabil ity, however, may violate tracer kinetic assumptions, namely, tracer may no longer be in steady state with the total (labeled and unlabeled) ligand . Tissue response be comes critically dependent on the dose of total ligand, and an accurate description of the cold ligand in the tissue is needed to properly model the system. Two alternative models have been applied to the receptor modeling prob lem, which reduces to describing the time-varying num ber of available receptor sites. The first (Huang et aI ., Dr . Morris ' current address is Neuroimaging and Drug Action Section , National Institute on Drug Abuse , 4940 Eastern Ave nue , Bldg C, Baltimore , MD 21224, U.S.A.
1989) contains only compartments for the hot ligand, 'hot only ' (HO), but indirectly accounts for the action of cold ligand at receptor sites via SA. The second stipulates sep arate compartments for the hot and cold ligands, 'hot and cold ' (HC), thus explicitly calculating available number of receptors. We examined these models and contrasted their abilities to predict PET activity, receptor availabil ity, and SA in each tissue compartment. For multiple injection studies, the models consistently predicted dif ferent PET activities-especially following the third in jection. Only for very high rate constants were the models identical for mUltiple injections. In one case, simulated PET curves were quite similar, but discrepancies ap peared in predictions of receptor availability. The HO model predicted nonphysiological changes in the avail ability of receptor sites and introduced errors of 3�O% into estimates of B'max for test data. We, therefore, strongly recommend the use of the HC model for all anal yses of multiple injection PET studies. Key Words: Specific activity-Receptor occupancy-B' max-Cold ligand . shown that a minimum of three injections (at high, low , and intermediate SA) is needed to estimate unique model parameters for the muscarinic recep tor ligand , MQNB (Delforge et a! ., 1990) . However, to achieve significant displacement of the radioli gand (i . e. , considerable receptor occupancy), the system must be perturbed by a nontrace dose of cold ligand. In such cases , the appropriate terms in a mathematical model must account for saturability of the receptor-binding compartment.
Most work in this field derives from a compart mental model proposed by Mintun et ai . (1984) , who described tracer kinetics in terms of three states: vascular, free and bound. To deal with the non steady state nature of experiments that modulate receptor occupancy, Huang and colleagues and oth ers (Huang et aI., 1986; Bahn et aI ., 1989; Farde et aI ., 1989; Votaw et aI ., 1993) have modeled the concentration of occupied recep tors as the ratio of the labeled ligand concentration to the SA of the injected ligand. Later, Delforge et al. (1989 Delforge et al. ( , 1990 proposed an alternative approach that modeled concentrations of both hot and cold ligands explicitly and required construction of a more complex system with twice the number of compartments. When, in our hands, the simpler model was unable to fit some experimental data from multiple injections, we decided to examine the two modeling approaches more closely . We found that the models do not always make the same pre dictions regarding measured PET concentrations, SA of tracer in various compartments, or receptor occupancy. Nor do they yield the same estimates for model parameters . To examine competing mod els, we implemented generalized formulations of each as well as a generalized version of time varying SA in the plasma. This report attempts to clarify the relationship between the two models, giving particular attention to the analysis of multiple injection experiments, which transiently cause ei ther complete or partial occupation of receptor sites. The strategy of this study is to compare out puts (i.e., PET activity) of the two models via sim ulations. This is done for different multiple injection protocols and parameter sets . These models can also be used to predict a time-varying fraction of receptor sites that are not occupied . The respective receptor availability plots are additional (and illus trative) bases on which to compare models. We demonstrate that differences in receptor availability can be traced to differences in how the models ac count for the binding of unlabeled ligand to receptor sites . This is of particular concern following low SA injections. Finally, we alert the reader to circum stances in which these distinctions between models are likely to be important and we attempt to assess the magnitude of the error that might be introduced (into estimates of B' max) were the "wrong" model used.
METHODS Theory
Currently, there are two distinct dynamic modeling ap proaches to the analysis of multiple-injection PET stud- Vol. 16, No. 5, 1996 ies. The first approach (Fig. lA) , chiefly advanced by Bahn and Huang and colleagues (Huang et aI., 1989; Bahn et aI., 1989) requires simultaneous solution of two or more nonlinear differential equations (i.e., one differen tial equation per compartment). The second approach (Fig. IB) , advanced by Delforge et al. (1989 Delforge et al. ( , 1990 Delforge et al. ( ,1991 Delforge et al. ( , 1993 ) is more complex, requiring the solution of twice as many equations. On first glance, the models may seem equivalent since the PET curve in both cases is con structed only from the compartments containing hot ligand. As will be demonstrated below, the models are not the same and should not be used interchangeably for anal ysis of multiple injection studies. Huang et al. (1989) and Bahn et al. (1989) put forth the first model specifically for simultaneous fitting of data from dual-injection PET stud ies; this model described only the kinetics of the labeled molecules. A single SA function, which did not distin guish between blood plasma and tissue compartments, was used to calculate the concentration of cold ligand in the bound compartment. This function was modded as a step, i.e., SA was a constant, SAl' following the first injection and a constant, SA2, following the second injec tion. We have generalized the function, SA(t), to account for the residual effect of all prior injections of hot and cold ligand. We also generalized the nonspecific binding into a distinct compartment and introduced the necessary first order rate constants rather than assuming, as did Mintun et al. (1984) originally, that nonspecific binding would be instantaneous and could be collapsed into the free com partment via a partition coefficient, f2. We have not re tained the dependence of the plasma extraction term, KI, on the SA of the injectate, since it was found to be min imal (Huang et aI., 1989) . In 1989, Delforge e:t aI., re ported that an initial, high SA injection followed by a completely cold injection would increase the precision of the parameter estimates, perhaps enough to estimate B' ma x and Ko separately. A third injection was necessary to isolate a unique solution to the parameter estimation problem. In contrast to the Huang approach, Delforge et al. (1989 Delforge et al. ( , 1990 proposed essentially separate models for labeled and unlabeled ligands. The "separate" models are coupled by their bound ligand compartments because the hot and cold ligand molecules compete for the same ligand binding sites, the initial number of which is B' max'
Model differences
Figures IA and B schematically depict the two models under consideration. The models allow the ligand to be in four different states: unreacted in plasma, unreacted (free) in tissue, nonspecifically bound, and bound to re ceptor. Table 1 provides a key to the symbolic notation. Unlike the formulation of Huang et al. (1989) ., we have included a nonspecific binding compartment that is dis tinct from the free space. The model equations for this model are (Le., compartments) representing the possible states of the labeled ligand, namely, the plasma state (,P'), free state (,F), receptor-bound state ('8'), or nonspecifically bound state CNS'). All of these states of the hot ligand contribute to the PET signal, hence their inclusion in the 'PET pixel.' As suggested by the heavy arrow labeled 'SA,' the HO model accounts for the effect of cold ligand binding to receptor via the bound concentration of hot ligand, B, and the SA. Losses from each hot compartment, labeled A, represent radioactive decay. The hot and cold (HC) model (8) includes boxes for each of the possible states of both the labeled and unlabeled ligand. The labeled ligand compartments are identical to (A). The states of the cold ligand are the plasma state (,pC'), free state (,FC>), receptor-bound state (,BC'), or nonspecifically bound state CNSC'). The dashed box enclosing the two bound compartments is to emphasize the competition between labeled and unlabeled ligand for a limited number of receptor binding sites. The HC model uses the SA to generate a plasma input function for cold ligand from the measured input function for hot ligand in the plasma. First-order rate constants (labeling each arrow) govern the transition of ligand from one state to another. Free ligand is transformed to bound ligand via its biomolecular association with available receptor sites, hence the shorthand label "koo nB'max" for the corresponding arrow. Losses from each hot compartment, labeled A, represent radioactive decay; there is no radioactive decay of cold ligand. 
(8)
We will refer to the model in Fig. IB as the "hot and cold" HC model. PET activity in either model is calcu lated by integrating each hot compartment's concentra tion over the length of the each scan and summing the values weighted by their respective volume fractions:
We have assumed for all of our work here that the vas cular volume fraction is between 0.03 and 0.05, while the three tissue compartments simultaneously occupy the re maining 95-97% of the total volume. Arrows indicating radioactive loss from each hot com partment with time constant, A, are included in both parts of Consider the practical differences between the models . Whereas the HO model formulation requires a single in put function, Cp(t), the HC model requires the specifica tion of input functions for both the labeled and unlabeled ligands: concentration of label in plasma, C/t), and con centration of cold ligand in plasma, CC pet). Although the hot input function can be measured directly (typically via J Cereh Blood Flow Metah. Vol. 16, No.5, 1996 blood sampling), the cold input function must be inferred as (11) This relationship between hot and cold inputs in the HC model is indicated in Fig. I B by the arrow labeled "SA" between the hot and cold plasma compartments. The SA function in Eq . I is the same one used in the HO model, but when invoked in the HC model, it refers only to the relationship between hot and cold ligand in the plasma.
Generalized SA function
The analytic expression for specific activity, SA(t), generalized to multiple injections is given below in Eqs .
12-14. It is based on our expectations of the dynamics of ligand molecules injected as a bolus into the blood. In its most general form SA(t) must include the radioactive de cay of hot tracer.
SA(t) (12)
For mUltiple injection studies, the SA. expressed as a unitless ratio of moles of hot to moles of total ligand, is a compound function summed over injections I ... n.
where, for example,
Concentration of labeled ligand in the plasma, normally given in units of activity, is converted into molar con centration using the formula for first order radioactive decay: activity = dN/dt = -AN, where N is the num ber of particles and A is the decay constant of the iso tope, U(t -t,) is the unit step function at the injection time, t, .
Metabolite-corrected plasma (MCP)(t) is typically a bi exponential equation that describes the decay-corrected, MCP radioactivity from a single bolus injection. MCP represents only the biological removal of tracer from plasma, distinct from the radioactive decay. The only as sumption here is that the biological decay function. MCP, is the same for all injections for labeled and unlabeled ligand . The only exception is the scale of the function, MCP(O+), which is the peak concentration of unmetabo lized ligand in the plasma. For fast bolus injections (cases 1-3), the peak occurs almost instantly after the start of injection-in such cases, we have fit the plasma radioac-tivity starting at the peak to a decaying bi-exponential function. Plasma data after each peak were still described by two decaying exponentials. As demonstrated below, the time dependence of SA for mUltiple injections of dif ferent SAs is a complicated function, which typically changes most rapidly immediately following each of the latter injections.
Description of cases examined
The behavior of the two models were compared for different parameter values and injection protocols, com prising cases 1-4. The cases examined were as follows: case I , high KD, large B'max, complete receptor occu pancy (for part of the study); case 2, very high transfer rate constants between plasma, free, and bound compart ments; case 3, low KD, small B'max, incomplete occu pancy; and case 4, high KD, moderate B'max, more real istic plasma curve.
Case 1 parameters were based on our preliminary anal ysis of PET studies with the dopamine transporter ligand, IIC-(CFT), in rhesus monkeys (Macaca mulatta). Case 2 parameters were derived from case I with K I , k2 in creased by one order of magnitude and kon, kotT increased by two orders of magnitude. Case 3 parameters were taken from subject 3 in the study of Huang et al. (1989) . The protocol presented by Huang et al. was extended to three injections in order to examine the response of the system once the second injection had caused partial re ceptor blockade. Because the University of California at Los Angeles (UCLA) researchers (Bahn et aI., 1989; Huang et aI., 1989) used an equilibrium fraction, f2' to partition the free compartment into free and nonspecifi cally bound ligand as well as a plasma to tissue transport constant, K I , which was permitted to vary with injection, we had to make certain approximations to their estimated values to conform with our model formulation. We emu lated their f2 value by fixing k, and kf> values at very high numbers in the ratio,. k,/kf, = IIf2 ' so that our nonspecific compartment would be in instantaneous equilibration with our free compartment, and the fraction, f2 ' of the sum of these two compartments would be available for binding to the receptor. Case 4 parameters were based on a subsequent analysis of IIC-CFT data from a mUltiple injection study of cynomologous monkeys (Morris et aI., 1995h) ; the plasma function used in these simulations rep resents the actual plasma data acquired. The particular protocols used in Cases I and 4 wer,� chosen as the result of a preliminary experimental design optimization study. In short, we chose the times, activities, and SAs of the three injections in order to minimize both the overall vari ance of the estimates and, specifically, the expected vari ance in B'max (Morris et aI., 1995a) .
Tissue parameters for each case are given in Table 2 , plasma parameters are given in Table 3 , and injection parameters are given in Table 4 . Plasma input curves (for cases 1-3) for multiple injection sllmulations were constructed by summing bi-exponentials scaled by their re spective injected activities, as described in the section on generalized SA function.
Generation of test data
We used the HC model to generate test data to be fit by the HO model. Parameters used were the same as given above for the simulations. To generate more realistic test data, we added noise the mean of which was proportional to the square root of the PET signal. Following Mazoyer et al. (1986) and others, we modeled the variance of the measurement error as proportional to the PET signal in the region (15) where Mi is the scan length and f is the proportionality constant that we refer to as the error level. Scan lengths were set uniformly at I min throughout the study. For triple injection simulations, specifications for each injec tion are given in Table 4 . Each three-injection simulation was terminated at 170 min, except in case 4, in which the simulation was 120 min long. Scan lengths for case 4 sim ulations were graduated (30 s for scans within 5 min after the injections and 3 min for later scans).
Numerical simulation and fittiJlg algorithms
All systems of ordinary differential equations were solved numerically with a commercially available soft ware system-IMSLI IDL (Sugar Land, TX, U.S.A.). Weighted nonlinear least squares data fitting was per formed using the modified Levenberg-Marquardt routine, NLINLSQ, provided by IMSLI IDL. The weighting ma trix supplied to the fitting algorithm consisted of the di agonal elements, U-2 i, which are the inverses of the mod eled variances for each residual. When either model was fitted to test data, five parameters (KI, k2 ' kon, kotr, and B'max) were allowed to vary, while k, and k" were fixed at their true values. Estimated values for B'max using the HC model are given, with error bars that represent one standard deviation as determined from the covariance matrix of the estimates.
RESULTS

Model predictions
One-and two-injection simulations. In the case of a single high SA injection, the number of bound molecules was very small, the available number of receptors �B'max' and the models identical. In fact, the models gave identical PET time activity curves for any single injection simulations. Adding a low SA injection to the experiment (following an initial high SA injection) caused hot ligand to be lost from " The decaying part of the curve was fit to a bi-exponen�ial function beginning at 0. 5 min postinjection :
Hence, the leading coefficient corresponding to that first pOint on the decaYing curve is labelled MCP(0.5 +).
the bound compartment and a corresponding in crease of radioligand in the free compartment. PET curves from the two models for two injections were nearly indistinguishable. Using case 1 parameters (see Methods section), there were only subtle dif ferences between models involving the extent to which the bound label was displaced and the free (and nonspecific) compartment(s) took up the freshly dissociated label (for results of two-injection simulations, see first 105 min of Figs. 2A,B) .
Three-injection simulations of HO and He models for high KD, full displacement (case I). In compar ing three-injection simulations, the different behav ior of the two models was more readily apparent. Figures 2A,B show the corresponding three injection simulations of the concentrations of la beled ligand in each compartment of the model as well as the total signal (the total curve corresponds to the integrand in Eq. 10) . Both simulations show that the initial high SA injection generates a tissue curve that is largely hot ligand in the bound state. The low SA injection at 30 min causes loss of the hot ligand from the bound compartment until nearly all of it has been displaced. However, after the (high SA) injection at 105 min, the HO model ( Fig. 2A) predicts a much more rapid increase in the amo � nt of bound hot ligand than does the He model (Fig.  2B) . Conversely, free hot ligand does not reach as high a concentration according to the HO model as with the He model. The overall difference is that the total curve in Fig. 2A peaks for the second time at 120 min at �0.001 pmoIlml, while the total la beled ligand in Fig. 2B peaks at 110 min at just 0.0007 pmol/ml. Furthermore, the bound curve in the HO model nearly reaches its peak value in stantly after the third injection, whereas the same curve in the He model increases gradually. Accord ing to the He model, the bound compartment does not peak until nearly 140 min, i.e., 35 min after the last injection.
The differences between HO and He can be un derstood further by plotting the available number of receptors (in pmoIlml) predicted by each model (Figs. 3A,B) . In both cases, the receptor availability is barely affected by the first high SA injection. Fol lowing the low SA injection, the introduction of a blocking dose of cold ligand causes the availability of receptor sites to drop precipitously to zero in both cases. While the receptors remain completely blocked in the HO simulation right up until the third injection, there is a slight gradual rise in the number of available receptors in the He simulation. This gradual rise continues after the injection at 105 min. In fact, the gradual increase in the number of open receptor sites continues (Fig. 3B ) for the He model independently of the third injection. The HO model (Fig. 3A) predicts no freeing up of receptor sites prior to injection three and a transient spike in avail able receptors to near maximum, B'm a x, immedi ately following the injection. Once the spike in re ceptor availability dissipates, the model predicts a gradual rise in open sites paralleling the other model. The possibility that numerical artifacts, e.g., round-off error, could have caused the transients in the receptor availability plot was investigated and found not to be a source of error. As we discuss in detail below, the difference in behavior of these two models relates to their respective applications of the SA function.
Simulated SA curves. Recall from the model dif ferences section, above, that the number of avail able receptors, shown in Fig. 3A is calculated as B a v ai l ab le (t) = B ' m a x -B(t)/SA(t)
whereas in Fig. 3B , the same quantity is calculated as, B a v ai l ab le (t) B'm a x -B(t) -Be(t). Activity ------------- ------------- • .
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, , 200 function (Eq. 11) . To see how SAB(t) differs from SA(t), SA in the plasma, we plot the log of SA by compartment (Fig. 4) based on the solution of the HC model. The curves do not include radioactive decay. The curve labeled 'p' is the generalized SA function that appears in the nonlinear term of the HO model and is described in analytical form, above (see Eqs. 12-14). Curves labeled 'f and 'b' are the SAs in the free and bound compartments, respectively, calculated by the HC model.
One unexpected, but characteristic, result of ,... .., plasma SA simulations was the over-and under shoots in the curve just after injections. That is, for syste:ms without radioactive decay, a compound plasma curve whose decaying portion we describe as a sum of bi-exponentials (Eq. 14) yields a SA function that is more complicated than a series of consitant levels between injections. The sizes of the over·· and undershoots are related to the relative sizes of the decay constants, a and [3, in the plasma equation.
Three-injection simulations of HO and HC mod els for very high rate constants (case 2). Based on our observation that the discrepancy between SA in the plasma and bound compartments correlates with the divergent behavior of the two models, we sought to identify regions of parameter-space for which the two models were indistinguishable for multiple injections. We hypothesized that if rate constants in the system are high enough, the recep tor compartment should equilibrate rapidly with the plasma compartment, thus equalizing their respec tive SAs. Through a series of simulations, we found that an order of magnitude increase in the values of Kl and kz, and an increase of two orders in kon and koff were sufficient to cause the SAs in each com partment to very nearly converge to a single curve (see Fig. 5A ). The bound SA, SAB(t), simulated via the HC model, is coincident with the generalized SA function everywhere except in the transients im mediately following the latter injections. In turn, the PET activity curves predicted by the two com peting models are nearly identical for case 2 param eters (Fig. 5B) , except, perhaps, for a mild discrep ancy in the peak following the last injection. In Fig.  5B , the HO model is displayed as a solid curve while the HC model is displayed as individual points. It should be noted that the rate constants required to make the models behave identically are quite high and are unlikely to correspond to any receptor ligands.
Three-injection simulations of HO and HC mod els for small KD, partial displacement (case 3). We looked next at a set of published parameters and injectlion specifications for the irreversible D2 an tagonist spiperone. One might postulate that if high rate constants narrowed the differences between plasma and bound SA (and, thus, between the pre dictions of the HO and HC models), then low rate constants might guarantee inequality of the models. We chose to make an additional comparison of modells using published parameter values suffi ciently different from those in cases 1 and 2 and with a clinically feasible experimental protocol. The case 3 parameters, used in Figs. 6 and 7 are derived from Huang et al. (1989) , who estimated model pa- Vol. 16, No.5, 1996 rameters for the irreversible ligand, [18F]f1uoro ethyl-spiperone. As listed in the Methods section, the first injection in case 3 is at high SA, while the second is at an intermediate level, which causes incomplete occupancy of the Dz receptors. The por tion of the case 3 simulation for the HO model (Fig.  6A) corresponding to the first two injections ap pears quite similar to the curves publi�hed in Huang et aI., 1989 for their two-injection experiments. To examine the behavior of both models after introduc tion of a large dose of cold, we added a third rela tively high SA (3,000 mCi/fLmole) injection and spaced the injections every 75 min.
Unexpectedly, predicted outputs for the two models for Case 3 parameters (Figs. 6A and B) were nearly identical throughout the course of the simu lated experiment. However, when we examined each model's prediction of available number of re ceptor sites, the difference between the two models emerged. Receptor availability, as predicted by the HO and HC models, is displayed in Fig. 7A and B, respectively. There was agreement between the models that the moderately low SA injection (68 mCi/fLmole) at 75 min was insufficient to cause >50% occupancy of available receptor sites at any time during the experiment. Nevertheless, there was a significant difference in the time course of receptor availability predicted by the two models. This discrepancy, which is reminiscent of that shown in Fig. 3 , centers on the apparent, high sen sitivity of the HO model prediction to abrupt changes in injected SA (notice the abrupt drop and equally sharp rise in receptor availability following the second and third injections). Contrast the be- Timp (min) havior of the curve in Fig. 7 A to the apparent in sensitivity to change in injected SA of the curve in � o 0.0002 of available receptor sites with the introduction of a final high SA injection (i.e., small mass of ligand molecules) at 150 min. To be certain that the calcu lations for Bavailable shown in Fig. 7 were not arti factual, we examined each of the individual terms that comprise Bavailable for each model as given in Eqs. 16 and 17 . The plots of each component of Bavailahle (data not shown) clearly indicated that the H&C Model by compartments generated by the HC model is in set in Figure 7B . The inset plot shows that for the particular parameter set and protocol of case 3, SAs in the plasma and bound compartments do not con verge following the third injection. Similarly, recep tor availability plots do not converge.
Parameter estimation
Finally, we contrasted the respective abilities of each model to recover the true parameter values from test data. Figure 8A portrays the estimated values for B' max based on fitting both models to test data generated with the HC model and case 1 set tings. The true value of B ' max is indicated on the graph. As the error level in the simulated data is decreased, the estimated value of B' max converges to the true value, and the precision of the estimate improves. Estimates based on the HO model are consistently very low and do not improve as the data become less noisy. B' max values at every error level were underestimated by -60% . Similarly, for case 4 parameters, the HC model is able to recover a value approaching the true B' max as the noise in the data decreases. As shown in Fig. 8B , the HO A three-injection study with high Ko and large cold dose in injection no. 2 (case 1) was examined.
For these parameter values, which derived from preliminary experimental work with a dopamine re uptake inhibitor, the differences between HO and HC models were quite apparent in the PET curves for multiple injection simulations. Furthermore , once we plotted the receptor availability as pre dicted by each model, it became increasingly clear that the HO model predicted a nonphysiological dis continuity in receptor availability following the third injection. The sharp rise in predicted receptor availability is a direct result of the abrupt change specified in the analytical SA function. These find ings were corroborated by our examination of case 3 parameters (low Ko, partial displacement with low SA injection). The PET curves for the two mod els looked the same but on examination of predicted receptor availability , model differences emerged.
As in case 1, the HC model predicted a gradually decreasing receptor availability after the low SA second injection that was unaffected by a later in jection of a small amount of high SA ligand. In con trast , the HO model predicted an abrupt drop in receptor availability immediately after the second injection and an equally abrupt rise after the third .
We believe that the ability of the model to correctly predict receptor availability is not an insignificant issue. It may be crucial when using PET to measure the effectiveness of neuropsychiatric drug treat ment on schizophrenics , for example, so that we be able to determine how many dopamine D2 sites re main available after haldol administration or how many serotonin 5-(HT) sites remain free after treat ment with an atypical neuroleptic.
As the more general of the two , we considered the HC model to be our reference and sought to determine when , if ever , the simpler HO model woulld be equivalent to it. Our real interest , though , was in the ability of these models to predict ligand behavior in multiple injection studies because there is evidence that a minimum of three injections is needed for identification of all (seven) model pa rameters (Delforge et aI. , 1990) . The following caveat is offered to investigators interested in using kinetic models to estimate pa rameters. Even when the two models seem identical vis-a-vis the forward problem, i.e. , they predict similar PET curves (as in case 3) , they will not nec essarily behave identically in the more important inverse problem , namely parameter estimation.
Most estimation methods rely explicitly or implic itly on the model equations and the gradient infor mation. Components of the gradient are the deriv atives of the compartmental concentrations with re spect to the parameters , and they determine the shape of the objective function to be minimized.
Components of the gradient are the derivatives of Eqs. 1-3 or 4-9, respectively, integrated over time.
Inspection of these equations reveals that the recep tor availability term (B ' max -total bound) figures prominently in many of them. If this term is calcu lated incorrectly, the direction of each step in the estimation procedure will be affec:ted adversely , possibly forcing the search algorithm into an unde sired local minimum of the objec:tive function in pa rameter space. Thus, even though two models may predict similar output curves for a given set of parameters , owing to a multiplicity of nearly equivalent local minima, they may not yield the same parameter estimates to a gIven set of PET data .
CONCLUSION
In this study , we have compared the behavior of the two models most widely cited in the literature for describing the kinetics of a neuroreceptor ligand , as measured by dynamic PET studies . The HO model , although used widely in various forms , is not equivalent to the HC model , which is less well known . The differences are not always apparent in the PET curves predicted by each model . In fact, the models are identical for single injection studies 
